Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Ciguatoxins Evoke Potent CGRP Release by Activation of Voltage-Gated Sodium Channel Subtypes NaV1.9, NaV1.7 and NaV1.1

F. Touska, S. Sattler, P. Malsch, RJ. Lewis, PW. Reeh, K. Zimmermann,

. 2017 ; 15 (9) : . [pub] 20170830

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18024684

Ciguatoxins (CTXs) are marine toxins that cause ciguatera fish poisoning, a debilitating disease dominated by sensory and neurological disturbances that include cold allodynia and various painful symptoms as well as long-lasting pruritus. Although CTXs are known as the most potent mammalian sodium channel activator toxins, the etiology of many of its neurosensory symptoms remains unresolved. We recently described that local application of 1 nM Pacific Ciguatoxin-1 (P-CTX-1) into the skin of human subjects induces a long-lasting, painful axon reflex flare and that CTXs are particularly effective in releasing calcitonin-gene related peptide (CGRP) from nerve terminals. In this study, we used mouse and rat skin preparations and enzyme-linked immunosorbent assays (ELISA) to study the molecular mechanism by which P-CTX-1 induces CGRP release. We show that P-CTX-1 induces CGRP release more effectively in mouse as compared to rat skin, exhibiting EC50 concentrations in the low nanomolar range. P-CTX-1-induced CGRP release from skin is dependent on extracellular calcium and sodium, but independent from the activation of various thermosensory transient receptor potential (TRP) ion channels. In contrast, lidocaine and tetrodotoxin (TTX) reduce CGRP release by 53-75%, with the remaining fraction involving L-type and T-type voltage-gated calcium channels (VGCC). Using transgenic mice, we revealed that the TTX-resistant voltage-gated sodium channel (VGSC) NaV1.9, but not NaV1.8 or NaV1.7 alone and the combined activation of the TTX-sensitive VGSC subtypes NaV1.7 and NaV1.1 carry the largest part of the P-CTX-1-caused CGRP release of 42% and 34%, respectively. Given the contribution of CGRP to nociceptive and itch sensing pathways, our findings contribute to a better understanding of sensory symptoms of acute and chronic ciguatera that may help in the identification of potential therapeutics.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024684
003      
CZ-PrNML
005      
20231002114411.0
007      
ta
008      
180709s2017 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/md15090269 $2 doi
035    __
$a (PubMed)28867800
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Touska, Filip $u Department of Anesthesiology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital Erlangen, Krankenhausstraße 12, 91054 Erlangen, Germany. touska@biomed.cas.cz. Department of Cellular Neurophysiology, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague 4, Czech Republic. touska@biomed.cas.cz.
245    10
$a Ciguatoxins Evoke Potent CGRP Release by Activation of Voltage-Gated Sodium Channel Subtypes NaV1.9, NaV1.7 and NaV1.1 / $c F. Touska, S. Sattler, P. Malsch, RJ. Lewis, PW. Reeh, K. Zimmermann,
520    9_
$a Ciguatoxins (CTXs) are marine toxins that cause ciguatera fish poisoning, a debilitating disease dominated by sensory and neurological disturbances that include cold allodynia and various painful symptoms as well as long-lasting pruritus. Although CTXs are known as the most potent mammalian sodium channel activator toxins, the etiology of many of its neurosensory symptoms remains unresolved. We recently described that local application of 1 nM Pacific Ciguatoxin-1 (P-CTX-1) into the skin of human subjects induces a long-lasting, painful axon reflex flare and that CTXs are particularly effective in releasing calcitonin-gene related peptide (CGRP) from nerve terminals. In this study, we used mouse and rat skin preparations and enzyme-linked immunosorbent assays (ELISA) to study the molecular mechanism by which P-CTX-1 induces CGRP release. We show that P-CTX-1 induces CGRP release more effectively in mouse as compared to rat skin, exhibiting EC50 concentrations in the low nanomolar range. P-CTX-1-induced CGRP release from skin is dependent on extracellular calcium and sodium, but independent from the activation of various thermosensory transient receptor potential (TRP) ion channels. In contrast, lidocaine and tetrodotoxin (TTX) reduce CGRP release by 53-75%, with the remaining fraction involving L-type and T-type voltage-gated calcium channels (VGCC). Using transgenic mice, we revealed that the TTX-resistant voltage-gated sodium channel (VGSC) NaV1.9, but not NaV1.8 or NaV1.7 alone and the combined activation of the TTX-sensitive VGSC subtypes NaV1.7 and NaV1.1 carry the largest part of the P-CTX-1-caused CGRP release of 42% and 34%, respectively. Given the contribution of CGRP to nociceptive and itch sensing pathways, our findings contribute to a better understanding of sensory symptoms of acute and chronic ciguatera that may help in the identification of potential therapeutics.
650    _2
$a zvířata $7 D000818
650    _2
$a peptid spojený s genem pro kalcitonin $x účinky léků $7 D015740
650    _2
$a vápník $x metabolismus $7 D002118
650    _2
$a ciguatera $x metabolismus $7 D036841
650    _2
$a ciguatoxiny $x chemie $x farmakologie $7 D002922
650    _2
$a ELISA $7 D004797
650    _2
$a lidé $7 D006801
650    _2
$a hyperalgezie $x chemicky indukované $7 D006930
650    _2
$a lidokain $x farmakologie $7 D008012
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mořské toxiny $x farmakologie $7 D008387
650    _2
$a membránové potenciály $x účinky léků $7 D008564
650    _2
$a myši $7 D051379
650    _2
$a myši transgenní $7 D008822
650    _2
$a napětím řízený sodíkový kanál, typ 1 $x účinky léků $7 D062550
650    _2
$a napěťově řízený sodíkový kanál, typ 9 $x účinky léků $7 D062556
650    _2
$a napětově řízený sodíkový kanál typ 11 $x účinky léků $7 D062558
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a receptory peptidu se vztahem ke genu kalcitoninu $x účinky léků $7 D018015
650    _2
$a tetrodotoxin $x farmakologie $7 D013779
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sattler, Simon $u Department of Physiology and Pathophysiology, Friedrich-Alexander-University Erlangen-Nuremberg, Universitätsstraße 17, 91054 Erlangen, Germany. simon.sattler@outlook.com.
700    1_
$a Malsch, Philipp $u Department of Physiology and Pathophysiology, Friedrich-Alexander-University Erlangen-Nuremberg, Universitätsstraße 17, 91054 Erlangen, Germany. philippmalsch@googlemail.com.
700    1_
$a Lewis, Richard J., $u Institute for Molecular Biosciences, IMB Centre for Pain Research, University of Queensland, 4072 St Lucia, Australia. r.lewis@uq.edu.au. $d 1957- $7 xx0250433
700    1_
$a Reeh, Peter W $u Department of Physiology and Pathophysiology, Friedrich-Alexander-University Erlangen-Nuremberg, Universitätsstraße 17, 91054 Erlangen, Germany. peter.reeh@fau.de.
700    1_
$a Zimmermann, Katharina $u Department of Anesthesiology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital Erlangen, Krankenhausstraße 12, 91054 Erlangen, Germany. katharina.zimmermann@fau.de.
773    0_
$w MED00165871 $t Marine drugs $x 1660-3397 $g Roč. 15, č. 9 (2017)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28867800 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20231002114409 $b ABA008
999    __
$a ok $b bmc $g 1316815 $s 1021605
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 15 $c 9 $e 20170830 $i 1660-3397 $m Marine drugs $n Mar. drugs $x MED00165871
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...